FdaApplication

NDA 209471

Back to search

Identifiers

Properties

PropertyValue
applicant_nameAFT PHARMACEUTICALS US INC
application_typeNDA
approval_date2023-03-01

Products (1)

ProductActive ingredientStrengthDosage form
COMBOGESICACETAMINOPHEN; IBUPROFEN325MG;97.5MGTABLET;ORAL

1 product